BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8951671)

  • 1. Expression of the neurofibromatosis 2 tumor suppressor gene product, merlin, in Schwann cells.
    Scherer SS; Gutmann DH
    J Neurosci Res; 1996 Dec; 46(5):595-605. PubMed ID: 8951671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of molecular domains of epitope-tagged merlin isoforms in Cos-7 cells and primary rat Schwann cells.
    Xu L; Gonzalez-Agosti C; Beauchamp R; Pinney D; Sterner C; Ramesh V
    Exp Cell Res; 1998 Jan; 238(1):231-40. PubMed ID: 9457076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interdomain binding mediates tumor growth suppression by the NF2 gene product.
    Sherman L; Xu HM; Geist RT; Saporito-Irwin S; Howells N; Ponta H; Herrlich P; Gutmann DH
    Oncogene; 1997 Nov; 15(20):2505-9. PubMed ID: 9395247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Merlin, the neurofibromatosis type 2 gene product, and beta1 integrin associate in isolated and differentiating Schwann cells.
    Obremski VJ; Hall AM; Fernandez-Valle C
    J Neurobiol; 1998 Dec; 37(4):487-501. PubMed ID: 9858254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subcellular localization and expression pattern of the neurofibromatosis type 2 protein merlin/schwannomin.
    Schmucker B; Ballhausen WG; Kressel M
    Eur J Cell Biol; 1997 Jan; 72(1):46-53. PubMed ID: 9013725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nf2 Mutation in Schwann Cells Delays Functional Neural Recovery Following Injury.
    Truong K; Ahmad I; Jason Clark J; Seline A; Bertroche T; Mostaert B; Van Daele DJ; Hansen MR
    Neuroscience; 2018 Mar; 374():205-213. PubMed ID: 29408605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tumor suppressor merlin interacts with microtubules and modulates Schwann cell microtubule cytoskeleton.
    Muranen T; Grönholm M; Lampin A; Lallemand D; Zhao F; Giovannini M; Carpén O
    Hum Mol Genet; 2007 Jul; 16(14):1742-51. PubMed ID: 17566081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between two isoforms of the NF2 tumor suppressor protein, merlin, and between merlin and ezrin, suggests modulation of ERM proteins by merlin.
    Meng JJ; Lowrie DJ; Sun H; Dorsey E; Pelton PD; Bashour AM; Groden J; Ratner N; Ip W
    J Neurosci Res; 2000 Nov; 62(4):491-502. PubMed ID: 11070492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Merlin differentially associates with the microtubule and actin cytoskeleton.
    Xu HM; Gutmann DH
    J Neurosci Res; 1998 Feb; 51(3):403-15. PubMed ID: 9486775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homotypic and heterotypic interaction of the neurofibromatosis 2 tumor suppressor protein merlin and the ERM protein ezrin.
    Grönholm M; Sainio M; Zhao F; Heiska L; Vaheri A; Carpén O
    J Cell Sci; 1999 Mar; 112 ( Pt 6)():895-904. PubMed ID: 10036239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ezrin, radixin, and moesin are components of Schwann cell microvilli.
    Scherer SS; Xu T; Crino P; Arroyo EJ; Gutmann DH
    J Neurosci Res; 2001 Jul; 65(2):150-64. PubMed ID: 11438984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization and functional domains of the neurofibromatosis type II tumor suppressor, merlin.
    Shaw RJ; McClatchey AI; Jacks T
    Cell Growth Differ; 1998 Apr; 9(4):287-96. PubMed ID: 9563848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurofibromatosis 2 tumor suppressor protein colocalizes with ezrin and CD44 and associates with actin-containing cytoskeleton.
    Sainio M; Zhao F; Heiska L; Turunen O; den Bakker M; Zwarthoff E; Lutchman M; Rouleau GA; Jääskeläinen J; Vaheri A; Carpén O
    J Cell Sci; 1997 Sep; 110 ( Pt 18)():2249-60. PubMed ID: 9378774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of the NF2 gene and merlin occur by the tumorlet stage of schwannoma development in neurofibromatosis 2.
    Stemmer-Rachamimov AO; Ino Y; Lim ZY; Jacoby LB; MacCollin M; Gusella JF; Ramesh V; Louis DN
    J Neuropathol Exp Neurol; 1998 Dec; 57(12):1164-7. PubMed ID: 9862639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional analysis of the neurofibromatosis type 2 protein by means of disease-causing point mutations.
    Stokowski RP; Cox DR
    Am J Hum Genet; 2000 Mar; 66(3):873-91. PubMed ID: 10712203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional analysis of neurofibromatosis 2 (NF2) missense mutations.
    Gutmann DH; Hirbe AC; Haipek CA
    Hum Mol Genet; 2001 Jul; 10(14):1519-29. PubMed ID: 11448944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation.
    Toledo A; Grieger E; Karram K; Morrison H; Baader SL
    PLoS One; 2018; 13(5):e0196726. PubMed ID: 29715273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired interaction of naturally occurring mutant NF2 protein with actin-based cytoskeleton and membrane.
    Deguen B; Mérel P; Goutebroze L; Giovannini M; Reggio H; Arpin M; Thomas G
    Hum Mol Genet; 1998 Feb; 7(2):217-26. PubMed ID: 9425229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Merlin knockdown in human Schwann cells: clues to vestibular schwannoma tumorigenesis.
    Ahmad Z; Brown CM; Patel AK; Ryan AF; Ongkeko R; Doherty JK
    Otol Neurotol; 2010 Apr; 31(3):460-6. PubMed ID: 20195187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of schwannomin in lens and Schwann cells.
    Claudio JO; Veneziale RW; Menko AS; Rouleau GA
    Neuroreport; 1997 May; 8(8):2025-30. PubMed ID: 9223096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.